AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 21271182
Drug: Isotonic solution
RxNorm normalized name: Isotonic solutions
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isotonic solution (Gatorade(®))
Trial: 11820367
Drug: Nasal immunization
RxNorm normalized name: Immune Globulin
DrugBank: Human immunoglobulin G (DB00028)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nasal immunization with glucosyltransferase-enriched preparation (E-GTF)
Trial: 30248217
Drug: N9-GP 40
RxNorm normalized name: GPS
DrugBank: Galinpepimut-S (DB17271)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: N9-GP 40 IU/kg once-weekly prophylaxis
Trial: 15374707
Drug: raloxifene hCL
RxNorm normalized name: raloxifene HCl
DrugBank: Raloxifene (DB00481)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: raloxifene hCL (60 mg)
Trial: 21795635
Drug: Combined bolus
RxNorm normalized name: Peumus boldus leaf extract
DrugBank: Boldo leaf extract (DB15815)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined bolus infusion of GH or saline and continuous stimulation by saline GH‐releasing hormone (GHRH), GHRP‐2, or both peptides after randomly ordered supplementation with placebo vs. E(2) (estrogen; women) and T (testosterone; men)
Trial: 23703041
Drug: Classical music
RxNorm normalized name: benzalkonium
DrugBank: Benzalkonium (DB11105)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Classical music therapy (15-minute sessions, twice a day for three consecutive days)
Trial: 30971301
Drug: Definitive concurrent
RxNorm normalized name: ESIKA PRO HD COLOR HIGH DEFINITION COLOR SPF 20 KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Definitive concurrent chemoradiotherapy (DCRT)
Trial: 28536825
Drug: Intramuscular clodronate
RxNorm normalized name: Clodronic acid
DrugBank: Clodronic acid (DB00720)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular clodronate (CLO) 200 mg/day i.m. for 10 days, followed by 200 mg/day i.m. for 6 days after 3 and 6 months, added to usual NSAIDs or analgesic drugs.
Trial: 28536825
Drug: Usual treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Usual treatment with anti-inflammatory or analgesic drugs (Control Group B).
Trial: 22327088
Drug: Vitamin E
RxNorm normalized name: Vitamin E
DrugBank: Vitamin E (DB00163)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vitamin E supplementation (268 mg·d⁻¹)
Trial: 10231510
Drug: 100 microg
RxNorm normalized name: Digoxin 100 microgram oral capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 microg recombinant human platelet‐derived growth factor‐BB daily
Trial: 25619170
Drug: Low-dose hydrocortisone
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose hydrocortisone therapy
Trial: 27869986
Drug: AD +
RxNorm normalized name: Stahist AD
DrugBank: Chlorcyclizine (DB08936)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: AD + PE (sertraline plus physical exercise)
Trial: 16365065
Drug: Fish oil
RxNorm normalized name: Fish oil
DrugBank: Fish oil (DB13961)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fish oil (5 mL daily for 3 months)
Trial: 9840607
Drug: Oxfendazole (OFZ)
RxNorm normalized name: Oxfendazole
DrugBank: Oxfendazole (DB11446)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxfendazole (OFZ) 30 mg/kg
Trial: 15203576
Drug: Insulin lispro
RxNorm normalized name: Insulin Lispro
DrugBank: Insulin lispro (DB00046)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Insulin lispro (IL) administered before meals
Trial: 2125938
Drug: Acipimox (AC)
RxNorm normalized name: acipimox
DrugBank: Acipimox (DB09055)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acipimox (AC) 500 mg with placebo
Trial: 17159193
Drug: Delayed zoledronic
RxNorm normalized name: Zoledronic Acid
DrugBank: Zoledronic acid (DB00399)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Delayed zoledronic acid (administered when LS or TH T score decreased to less than -2.0 or when a nontraumatic fracture occurred)
Trial: 17962050
Drug: Calcium dobesilate
RxNorm normalized name: CALCIUM DOBESILATE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium dobesilate (500mg capsules twice a day for 3 months)
Trial: 19636533
Drug: Intensive insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intensive insulin therapy (target BG 4.4-6.1 mmol/L)
Trial: 12660335
Drug: Sustained-release diltiazem
RxNorm normalized name: diltiazem
DrugBank: Diltiazem (DB00343)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sustained-release diltiazem 120 mg twice daily
Trial: 12747344
Drug: Oral morphine
RxNorm normalized name: morphine Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral morphine (30 mg) plus lorazepam (1 mg)
Trial: 12859700
Drug: bupropion SR
RxNorm normalized name: Bupropion Hydrochloride 100 MG Oral Tablet, Extended Release, 12 HR [BUPROPION SR]
DrugBank: Bupropion (DB01156)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: bupropion SR 300 mg daily for 7 weeks
Trial: 2049964
Drug: Ofloxacin 300
RxNorm normalized name: ofloxacin 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ofloxacin 300 mg b.i.d.
Trial: 2049964
Drug: Trimethoprim +
RxNorm normalized name: Trimethoprim
DrugBank: Trimethoprim (DB00440)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Trimethoprim + Sulfamethoxazole (TMP 800 mg + SMX 160 mg), 1 tablet, b.i.d.
Trial: 24496960
Drug: Traditional dosing
RxNorm normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Traditional dosing (for older patients with PNA ≥10 days)
Trial: 12105816
Drug: Zinc sulfate
RxNorm normalized name: Zinc Sulfate
DrugBank: Zinc acetate (DB14487)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Zinc sulfate supplementation (7.7 micromol zinc sulfate, 50 mg elemental zinc) for 90 days
Trial: 21163569
Drug: Intravesical BCG
RxNorm normalized name: BCG, live, Tice strain
DrugBank: Bacillus calmette-guerin substrain tice live antigen (DB10343)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravesical BCG (81 mg)
Trial: 19139780
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose folic acid (5 mg/day)
Trial: 19139780
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose folic acid (0.5 mg/day)
Trial: 12504938
Drug: Isosorbide mononitrate
RxNorm normalized name: Isosorbide Mononitrate
DrugBank: Isosorbide mononitrate (DB01020)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Isosorbide mononitrate 40 mg
Trial: 7647732
Drug: Nedocromil sodium
RxNorm normalized name: Nedocromil Sodium
DrugBank: Nedocromil (DB00716)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nedocromil sodium 8 mg/24 h
Trial: 8388286
Drug: Cimetidine suspension
RxNorm normalized name: Cimetidine
DrugBank: Cimetidine (DB00501)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cimetidine suspension
Trial: 11798458
Drug: Single dose
RxNorm normalized name: Citrucel Single Dose Packets (Orange)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single dose of consensus interferon (IFN-con1)
Trial: 21720656
Drug: Cetaphil RestoradermTM
RxNorm normalized name: CETAPHIL
DrugBank: Octocrylene (DB09535)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cetaphil RestoradermTM Moisturizer (CRM) with topical steroid
Trial: 28368936
Drug: Computer-controlled continuous
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Computer-controlled continuous infusion of phenylephrine
Trial: 21896097
Drug: Rifaximin 550
RxNorm normalized name: rifAXIMin 550 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rifaximin 550 mg once daily for 14 days
Trial: 7821746
Drug: C-peptide administration
RxNorm normalized name: peptide-T
DrugBank: Peptide-T (DB19279)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: C-peptide administration
Trial: 3062253
Drug: Rapid rotation
RxNorm normalized name: Abreva Rapid Pain Relief
DrugBank: Glycerin (DB09462)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rapid rotation (change of drugs every 2-3 weeks)
Trial: 27267880
Drug: Low-dose rotigotine
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose rotigotine (≤6 mg/24 h for early PD or ≤8 mg/24 h for advanced PD)
Trial: 27267880
Drug: Low-dose rotigotine
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose rotigotine
Trial: 26605991
Drug: linagliptin 5
RxNorm normalized name: linagliptin 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: linagliptin 5 mg once daily
Trial: 12501875
Drug: Ketotifen fumarate
RxNorm normalized name: Ketotifen Fumarate
DrugBank: Ketotifen (DB00920)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ketotifen fumarate 0.025% ophthalmic solution
Trial: 1963650
Drug: Conjugated estrogens
RxNorm normalized name: Conjugated Estrogens
DrugBank: Conjugated estrogens (DB00286)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Conjugated estrogens (0.6 mg/kg/day for 5 days)
Trial: 9727567
Drug: Saquinavir (SQV)
DrugBank: Saquinavir (DB01232)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Saquinavir (SQV) treatment
Trial: 19801052
Drug: Twice-daily physiotherapy
RxNorm normalized name: clindamycin
DrugBank: Clindamycin (DB01190)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Twice-daily physiotherapy
Trial: 16541783
Drug: 0.2 mg
RxNorm normalized name: niacin 0.2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.2 mg x kg(‐1) LCT propofol
Trial: 30149145
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no further treatment)
Trial: 16825288
Drug: Low-dose amiodarone
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose amiodarone alone
Trial: 348308
Drug: Cis-dichlorodiammineplatinum(II) single
RxNorm normalized name: CIS-DIAMMINEDICHLOROPLATINUM II
DrugBank: Cisplatin (DB00515)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cis-dichlorodiammineplatinum(II) single dose of 100 mg/m2 iv every 3-4 weeks
Trial: 17522560
Drug: Oral aripiprazole
RxNorm normalized name: Aripiprazole
DrugBank: Aripiprazole (DB01238)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Oral aripiprazole
Trial: 9564119
Drug: Chlorpromazine (CLO)
RxNorm normalized name: Chlorpromazine
DrugBank: Chlorpromazine (DB00477)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Chlorpromazine (CLO) (50 mg/day) + Dexamethasone (DEX) (2 mg/day)
Trial: 31943693
Drug: Drug-eluting stent
RxNorm normalized name: Fraxinus velutina pollen
DrugBank: Fraxinus velutina pollen (DB10455)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drug-eluting stent (DES; Medtronic, Minneapolis, Minnesota)
Trial: 24857827
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg fluoxetine daily for 3 weeks
Trial: 6463391
Drug: Propranolol 40
RxNorm normalized name: propranolol 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol 40 mg b.i.d.
Trial: 28731567
Drug: 8-week sham
RxNorm normalized name: lacosamide
DrugBank: Lacosamide (DB06218)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: 8-week sham acupuncture treatment
Trial: 7193307
Drug: Levodopa administered
RxNorm normalized name: Levodopa
DrugBank: Levodopa (DB01235)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Levodopa administered by mouth
Trial: 10355005
Drug: Monthly topical
RxNorm normalized name: tobramycin
DrugBank: Tobramycin (DB00684)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Monthly topical fluoride treatments with 2% NaF for two children.
Trial: 1769603
Drug: Sublingual nifedipine
RxNorm normalized name: Nifedipine
DrugBank: Nifedipine (DB01115)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sublingual nifedipine (used only if diastolic pressure of 110 mmHg or more)
Trial: 23811112
Drug: Danoprevir 300
RxNorm normalized name: Danoprevir
DrugBank: Danoprevir (DB11779)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Danoprevir 300 mg every 8 hours
Trial: 23811112
Drug: Danoprevir 600
RxNorm normalized name: Danoprevir
DrugBank: Danoprevir (DB11779)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Danoprevir 600 mg every 12 hours
Trial: 23811112
Drug: Danoprevir 900
RxNorm normalized name: Danoprevir
DrugBank: Danoprevir (DB11779)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Danoprevir 900 mg every 12 hours
Trial: 31852712
Drug: Ascorbic acid
RxNorm normalized name: Ascorbic Acid
DrugBank: Ascorbic acid (DB00126)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ascorbic acid (1500 mg), thiamine (100 mg), hydrocortisone (50 mg) every 6 hours for 4 days
Trial: 8883124
Drug: Parathyroidectomy followed
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Parathyroidectomy followed by calcitriol therapy (0.25 micrograms b.i.d. for 12 months)
Trial: 17161052
Drug: Invasive treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Invasive treatment strategy
Trial: 15956631
Drug: Conservative treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conservative treatment strategy
Trial: 21641274
Drug: Laboratory-guided preemptive
RxNorm normalized name: guaifenesin
DrugBank: Guaifenesin (DB00874)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Laboratory-guided preemptive therapy
Trial: 7575754
Drug: Rapid-release film-coated
RxNorm normalized name: acetaminophen
DrugBank: Acetaminophen (DB00316)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rapid-release film-coated tablet (B)
Trial: 8304056
Drug: Indomethacin bolus
RxNorm normalized name: Indomethacin
DrugBank: Indomethacin (DB00328)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Indomethacin bolus injection followed by continuous infusion
Trial: 31542988
Drug: Change over
RxNorm normalized name: colloidal oatmeal
DrugBank: Colloidal oatmeal (DB11286)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Change over time in TRQ between older and younger participants by treatment arm (CAE and EDU)
Trial: 11139541
Drug: Activated charcoal
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Activated charcoal (5 g, four times a day, starting 3 hours after pill intake on cycle days 12, 13, and 14)
Trial: 6677074
Drug: Multi-therapy
RxNorm normalized name: Parasedge Multi
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multi-therapy
Trial: 25517348
Drug: Intraarterial treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intraarterial treatment plus usual care
Trial: 8398292
Drug: BCG-RIVM -
RxNorm normalized name: Tice BCG
DrugBank: Bacillus calmette-guerin substrain tice live antigen (DB10343)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BCG-RIVM - 6 weekly instillations
Trial: 2974775
Drug: Non-insulin treated
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Non-insulin treated patients
Trial: 7745465
Drug: Avoidance of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Avoidance of aspirin and NSAIDs
Trial: 30043415
Drug: Music therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Music therapy during hospitalisation (twice a week for four to six weeks)
Trial: 20456191
Drug: Menthol 10%
RxNorm normalized name: MENTHOL 10% CREAM,TOP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Menthol 10% solution
Trial: 25504995
Drug: AICS-Bud 1
RxNorm normalized name: Clove buds
DrugBank: Clove (DB10672)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AICS-Bud 1 mg
Trial: 27103548
Drug: Yoga intervention
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Yoga intervention (2× weekly yoga classes for 12 weeks, complemented by regular home practice guided by a manual)
Trial: 8602179
Drug: Beta carotene
RxNorm normalized name: Beta Carotene
DrugBank: Beta carotene (DB06755)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beta carotene (50 mg on alternate days)
Trial: 31732867
Drug: Pre-operative meloxicam
RxNorm normalized name: lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pre-operative meloxicam administration
Trial: 22134736
Drug: Subcutaneous closed-suction
RxNorm normalized name: cetylpyridinium
DrugBank: Cetylpyridinium (DB11073)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Subcutaneous closed-suction drainage
Trial: 11292293
Drug: Mycophenolate mofetil
RxNorm normalized name: Mycophenolate Mofetil
DrugBank: Mycophenolate mofetil (DB00688)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Mycophenolate mofetil (MMF) combined with cyclosporin (CyA) and steroids (Pred)
Trial: 15243302
Drug: Subcutaneous treprostinil
RxNorm normalized name: Treprostinil
DrugBank: Treprostinil (DB00374)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Subcutaneous treprostinil sodium (10 ng/kg/min for 72 hours)
Trial: 15243302
Drug: Subcutaneous treprostinil
RxNorm normalized name: Treprostinil
DrugBank: Treprostinil (DB00374)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Subcutaneous treprostinil sodium
Trial: 11341175
Drug: Maternal serum
RxNorm normalized name: Serum, horse
DrugBank: Serum, horse (DB14613)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Maternal serum natural antibodies (N‐Ab) of IgG class to proteins MBP, S100, ACBP14/18 and MP65
Trial: 1426372
Drug: Gonadotropin-releasing hormone
RxNorm normalized name: Gonadotropin-releasing hormone
DrugBank: Gonadorelin (DB00644)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Gonadotropin-releasing hormone agonists (GnRH-a)
Trial: 31520543
Drug: Probiotic lozenges
RxNorm normalized name: Rezyst Probiotic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Probiotic lozenges
Trial: 23651846
Drug: Nutrient infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nutrient infusion into duodenum
Trial: 12918546
Drug: Valsartan with
RxNorm normalized name: Valsartan
DrugBank: Valsartan (DB00177)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Valsartan with ACE inhibitor and beta-blocker
Trial: 2826549
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of Lisinopril and HCTZ
Trial: 26659583
Drug: HU +
RxNorm normalized name: Hu-PHEC Liver
DrugBank: Hu-PHEC Liver (DB18347)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HU + imatinib (HU 500 mg BID + imatinib 400 mg QD)
Trial: 7608347
Drug: Group cognitive-behavioral
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group cognitive-behavioral therapy (CBT) for 12 weeks
Trial: 25257616
Drug: Radial shock
RxNorm normalized name: methyl salicylate
DrugBank: Methyl salicylate (DB09543)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Radial shock wave therapy (RSWT) - four sessions, once weekly
Trial: 9407259
Drug: Creatine monohydrate
RxNorm normalized name: Creatine Monohydrate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Creatine monohydrate (21 g.day-1)
Trial: 11113218
Drug: rt-PA treatment
RxNorm normalized name: rt-PA
DrugBank: Alteplase (DB00009)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: rt-PA treatment within 0 to 90 minutes
Trial: 11239184
Drug: rt-PA treatment
RxNorm normalized name: rt-PA
DrugBank: Alteplase (DB00009)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: rt-PA treatment
Trial: 27346078
Drug: Polydextrose at
RxNorm normalized name: Polydextrose
DrugBank: Polydextrose (DB14836)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Polydextrose at 50 g (positive control, single-dose study)
Trial: 7825998
Drug: Methylprednisolone treatment
RxNorm normalized name: Methylprednisolone
DrugBank: Methylprednisolone (DB00959)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Methylprednisolone treatment group
Trial: 7787215
Drug: GRP infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: GRP infusion
Trial: 24700254
Drug: Intranasal PH94B
RxNorm normalized name: influenza A virus (H1N1) antigen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intranasal PH94B
Trial: 24405979
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of low dose aspirin (75 mg daily) and low-molecular-weight heparin
Trial: 9022487
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose aspirin (75 mg daily)
Trial: 8089640
Drug: 250 mg
RxNorm normalized name: rutin 250 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 250 mg of oral terbinafine once daily for 2 weeks
Trial: 8089640
Drug: 500 mg
RxNorm normalized name: bran 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500 mg of oral griseofulvin once daily for 2 weeks
Trial: 15142150
Drug: Desmopressin nasal
RxNorm normalized name: desmopressin nasal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Desmopressin nasal spray
Trial: 18588736
Drug: ganciclovir 10
RxNorm normalized name: Ganciclovir
DrugBank: Ganciclovir (DB01004)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: ganciclovir 10 mg/kg bodyweight for 21 days
Trial: 8819063
Drug: Conservative treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conservative treatment (Control)
Trial: 21159786
Drug: Magnesium citrate
RxNorm normalized name: Magnesium Citrate
DrugBank: Magnesium (DB14513)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Magnesium citrate (500 mg elemental Mg/d)
Trial: 10930898
Drug: Cisapride 10
RxNorm normalized name: cisapride 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cisapride 10 mg t.d.s. and 20 mg b.d. (in patients with abnormal baseline electrogastrograms)